Stay updated on Pemigatinib Dose-Escalation Clinical Trial
Sign up to get notified when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.

Latest updates to the Pemigatinib Dose-Escalation Clinical Trial page
- Check3 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0. This represents a backend/template update and does not alter the study details shown on the page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 on the page, indicating a newer build of the site; no substantive changes to the study details are reflected.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedPage revision tag updated from v3.6.4 to v3.6.5. This reflects a new page version without changing the substantive study content.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, indicating a minor version update to the page/system.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page's revision indicator was updated from v3.6.0 to v3.6.3 in the footer, reflecting a version bump without altering the displayed study details.SummaryDifference0.0%

- Check95 days agoChange DetectedThe page now indicates that recruitment has ended, and additional user-oriented sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' have been added, while the 'Intervention/Treatment' header formatting was adjusted and the revision tag updated.SummaryDifference0.2%

Stay in the know with updates to Pemigatinib Dose-Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.